Henry P

Monash MBBS V | BMedSc (Hons) candidate | Urology research

[Henry P @Henry_YC_Pan]

Dr Niranjan Sathianathen, presenting 3 abstracts on LVI in bladder cancer, taxable therapy in mCrPC and biomarkers in prostate biopsies. Smashed it! @AusYURO #SIU2U #SIU2018

[Henry P @Henry_YC_Pan]

A/Prof @JGrummet on MRI, PCa diagnosis and targeting. Avoid Bx and “neo AS” if PSAD <0.1 and experienced MRI radiologist. If PSAD >0.1, risk assess and consider TP biopsy with Ginsburg protocol. #SIU2U #SIU2018 @ArveenKalapara

[Henry P @Henry_YC_Pan]

MR-TRUS fusion biopsies in transperineal biopsies improve cancer detection #SIU2U #SIU2018. Alternative to cognitive or in-bore targeting.

[jeremy grummet @JGrummet]

#SIU2U #SIU2018 Dr Sunao Shoji shows the advantages of #transperineal #prostatebiopsy in Controversies in Urology session on now.

[Tatenda Nzenza @DrTNzenza]

@Henry_YC_Pan presenting his "Samurai study" @AusYURO #SIU2U #SIU2018 @ArveenKalapara

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Reminder by @shomik_s to consider conditional life expectancy when discussing options with older patients #SIU2U #SIU2018

[Henry P @Henry_YC_Pan]

Lack of funding/reimbursement and clinician recognition/knowledge in biomarkers limits its use in Europe. Unsurprising, mpMRI most well known amongst polled clinicians. @Tilki_De #SIU2U #SIU2018

[soria @jsoriamd]

Great graphics and global overview on cancer prevalence and therapeutic improvements in this article. Overall cancer survival rates have moved from 50% end of the 70s to 67% in 2013.
https://t.co/VAxJFDxz5j

[Arveen Kalapara @ArveenKalapara]

Several biomarkers available, but limited for prediction of treatment response in metastatic disease, in part due to heterogeneity. Promising evidence for CTCs and cfDNA from Prof Jenster #APCC18

[Stacy Loeb, MD @LoebStacy]

Excellent lecture by John Violet on #PSMA theranostics including the recent LuPSMA trial & impressive images of exceptional responders from @DrMHofman #apcc18

[Henry P @Henry_YC_Pan]

Thanks Prof @mfrydenberg for the great talk on PSMA PET/CT and it’s role in BCR and the role of SUVmax in correlation w Grade Group. Complementary PSMA PET and MRI for imaging in recurrence - great argument for PSMA PET/MRI. @JGrummet #prostatecancer #APCC18

[Henry P @Henry_YC_Pan]

Open v robotic RP phase 3 RCT out of QLD n=308 - No differences shown #prostatecancer #openvsrobotic #APCC18 https://t.co/PSPhodrihV

[Henry P @Henry_YC_Pan]

Open vs robotic RP debate - n=308 phase 3 RCT in QLD found no difference in oncological outcomes between arms. Lower period complications and blood loss - A/Prof Yaxley #prostatecancer #APCC18

[Henry P @Henry_YC_Pan]

@ArveenKalapara presenting brilliant research on PSMA PET/CT at #APCC18 @AusYURO

[Henry P @Henry_YC_Pan]

Marked heterogeneity in oligometastatic disease - difficult landscape to navigate #prostatecancer #APCC18

[Samir Taneja @tanejauro]

Fascinating discussion on hottest topic in #prostatecancer at #apcc2018 Is it possible to be ‘a little bit’ metastatic? @AustProstate

[Stacy Loeb, MD @LoebStacy]

Potential benefits of local treatment in metastatic #prostatecancer -late local complications in more than half of mCRPC patients without prior primary therapy. High complication rate for palliative local therapy at later stage. Also may alter tumor biology -@ChapinMD #apcc18

[YURO @AusYURO]

Great work by @Henry_YC_Pan @ArveenKalapara @DrGhadirOmran #APCC18

[Dr. Steven Kaplan @MaleHealthDoc]

Interesting finding that cognitive biopsy of MRI lesions NO DIFFERENT than MRI guided biopsy in detecting Prostate Cancer. - Yaxley @AustProstate #apcc18 @medivizor @MountsinaiUro @UrologyTimes @NYCRoboticTeam

[Henry P @Henry_YC_Pan]

#ArtificialIntelligence is the future in Urology, #prostatecancer and medicine in general used in identifying abnormalities in histo/imaging, decision making and risk stratification. #APCC18

[jeremy grummet @JGrummet]

A surprise? Sarcasm surely! Congrats @szaby2 et al for showing up #TRUS biopsy (again) as the dangerous procedure it is. @ProstateCambrdg @USANZUrology @PCFA @MovemberAUS @CCSMonash